NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome
Interventions: Understanding MRI in MS (website), Control website
Countries: Germany
Magnetic resonance imaging (MRI) results play a major role in the lives of people with multiple sclerosis (pwMS). Even though MRI is used for diagnosis, prognosis and therapy control, pwMS' knowledge concerning this complex matter is scarce. Without adequate disease-specific knowledge, pwMS cannot truly make an informed choice when considering their MRI results (e.g. necessity of future MRI scans or therapy change). The investigators have developed an innovative, evidence-based and interactive online education tool called "Understanding MRI in MS", which incorporates all relevant information about MRI in MS and its implications in disease management. In this randomized, controlled and double-blind trial the tool's effect on MRI-specific knowledge, self-perceived competence and involvement in medical decision, that are based on MRI results will be assessed.
Sex: ALL
Age: 18 Years to 65 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * 18 years 65 years * MRI within 6 weeks to 6 months * internet access AND * diagnosis of relapsing-remitting MS (RRMS) according to the McDonald criteria (Thompson et al., 2018), \<10 years disease duration + active disease course (i.e. therapy change or new T2 lesion within the previous year) OR * clinically isolated syndrome (CIS) (with at least one MS-typical T2 lesion) Exclusion Criteria: * diagnosis of secondary-progressive MS * diagnosis of primary-progressive MS * diagnosis or suspected central nervous system disease other than MS * severe cognitive deficit * major psychiatric illness * patients who are related to medical personnel
- Hamburg, Germany